-
Lubin Family Foundation Scholar Award Symposium highlights tomorrow’s cancer research leaders
The Richard K. Lubin Family Foundation's commitment to advancing cancer research was on display at the Lubin Family Foundation Scholar Award Annual Symposium.
-
Funding the future: Focusing on excellence through endowments
Earlier detection. Better treatments. More time with loved ones. Breakthroughs in cancer care don’t happen by chance—they’re driven by exceptional faculty pursuing bold ideas.
-
Turning miles into meaning
Running the Boston Marathon® for the Dana-Farber Marathon Challenge team in April or participating in the annual Jimmy Fund Walk for Dana-Farber presented by Hyundai in October are two ways to contribute to our mission while having fun outdoors.
-
National Cancer Center
National Cancer Center awarded two new postdoctoral fellowships to Dana-Farber researchers Shelby Roseman, PhD, and Kaiwen Sun, PhD, and has renewed second-year funding for Katharina Hoebel, MD, PhD, and Diego Martinez Alonso, PhD. The gift of $488,000 enables these investigators to pursue innovative cancer research and strengthens their path towards independent research careers, helping accelerate…
-
Fostering patient-centered research
How can exercise and diet improve the cognitive and physical abilities of cancer survivors 65 and older? Can artificial intelligence tools analyze clinical notes and other data in electronic medical records to determine which treatments are most effective?
-
The Impact You Have Made Possible
Each year, Dana-Farber Cancer Institute aspires to provide the care and treatment our patients deserve. We are able to achieve these ambitions because of our dedicated donor community.
-
Advancing Parkinson’s research: Spiegelman’s groundbreaking work
From a remarkable act of generosity, the Tyler Family has donated $3 million to establish the Tyler Family Fund for Parkinson's Research, supporting the groundbreaking work of Bruce Spiegelman, PhD, the Stanley J. Korsmeyer, MD, Professor of Cell Biology and Medicine at Harvard Medical School.
-
Defying Cancer 26.2 miles at a time
On Monday, April 21, more than 500 runners completed the 129th Boston Marathon® as part of the 2025 Dana-Farber Marathon Challenge (DFMC) team.
-
Impactful Progress: President and CEO Benjamin L. Ebert, MD, PhD, reflects on his first year and strategic vision for the future of Dana-Farber Cancer Institute
As Dana-Farber Cancer Institute marks a transformative year under the leadership of President and CEO and Susan Smith Professor of Medicine at Harvard Medical School Benjamin L. Ebert, MD, PhD, Impact spoke with him about the significant milestones achieved and the exciting path ahead.
-
Conquering blood cancers is focus of Blood Cancer United grants
Each year, nearly 200,000 Americans are diagnosed with leukemia, lymphoma, myeloma, or another bloodborne cancer. Blood Cancer United has awarded $4.2 million in grants to eight Dana-Farber physician-scientists working to better understand, treat, and potentially cure these often deadly diseases.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.